Moreover, patients with Alzheimer's disease, the most common type of dementia, have high TNF-α levels (12), and perispinal etanercept (a TNF inhibitor) has been shown to rapidly improve verbal fluency and aphasia in patients with Alzheimer's disease (13). Here, TNF is linked to Alzheimer disease.